FOMAT

Gastrointestinal Clinical Trials

Precision Medicine in Gastrointestinal Trials: A New Frontier

The advent of precision medicine marks a transformative era in healthcare, promising highly individualized treatment strategies that are revolutionizing patient care. This approach is particularly impactful in the realm of gastrointestinal (GI) disorders, a field characterized by a wide array of…

Read More
Crohn's disease study identifies genetic variant with potential to personalize treatment

Genetic Marker Identified for Crohn’s Disease Drug Response

The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn’s disease has identified a genetic marker that could individualize drug treatment. UK-Wide Collaboration and Study Findings A UK-wide collaboration led…

Read More